ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of the University of Texas M D Anderson Cancer Center in Houston. While supporting current guidelines on screening, he explained to Peter Goodwin why the benefits are less than is often assumed and why he doesn’t support indiscriminate screening of women under 50 years of age.[audio:https://www.audiomedica.com/podcasting/oncology/130322DonaldBerryPODCASTLoRes.mp3]
You may also like...
Audio Journal of Oncology 14.2, March 2006 11 Jan, 2006 Young Women with HER2+ Early Breast Cancer Better with Mastectomy 24 Aug, 2016 Pembrolizuab Monotherapy Extended Survival in Advanced Lung Cancer 8 Jun, 2018 Cancers of unknown primary site: biomarker profiling prompts paradigm shift in treatment decision-making 18 Oct, 2013
- Previous story Low risk prostate cancer: scope and benefits from reducing overtreatment
- Next story Which patients for bisphosphonate control of breast cancer metastasis?
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014